Science News
from research organizations

Hodgkin's lymphoma: Treatment can have late sequelae

Date:
May 27, 2015
Source:
Deutsches Aerzteblatt International
Summary:
In Hodgkin's lymphoma -- cancer of the lymph nodes -- nine out of ten patients survive the disease, thanks to the highly effective treatments that are now available. Depending on the type of treatment given, however, there may be late sequelae, researchers report. These authors studied the question of which types of treatment were more likely to be followed by the development of secondary malignant neoplasia, and they quantified the risk of such an event as a function of the treatment received.
Share:
FULL STORY

Hodgkin's lymphoma -- cancer of the lymph nodes -- arises in more than 150 children and adolescents in Germany each year. Nine out of ten patients survive the disease, thanks to the highly effective treatments that are now available. Depending on the type of treatment given, however, there may be late sequelae, as discussed by Wolfgang Dörffel and colleagues in an original article in the current issue of Deutsches Ärzteblatt International.

These authors studied the question of which types of treatment were more likely to be followed by the development of secondary malignant neoplasia, and they quantified the risk of such an event as a function of the treatment received.

Hodgkin's lymphoma is usually treated with both chemotherapy and radiotherapy. Depending on the particular combination of agents used, and on the intensity of treatment, some patients develop other types of cancer years afterward; for example, some patients treated with radiotherapy later develop malignant neoplasms as a consequence of their treatment.

Overall, one in every four or five patients treated for Hodgkin's lymphoma in childhood or adolescence developed a second type of cancer within 30 years of treatment.

The authors recommend that patients be informed about the possible late sequelae of treatment and undergo regular follow-up. Moreover, radiotherapy in children and adolescents should be given at reduced doses or avoided entirely.


Story Source:

Materials provided by Deutsches Aerzteblatt International. Note: Content may be edited for style and length.


Journal Reference:

  1. Doerffel W, Riepenhausen M, Lüders H, Braemswig J, Schellong G. Secondary malignancies following treatment for Hodgkin’s lymphoma in childhood and adolescence—a cohort study with more than 30 years’ follow-up. Dtsch Arztebl Int, May 2015 DOI: 10.3238/arztebl.2015.0320

Cite This Page:

Deutsches Aerzteblatt International. "Hodgkin's lymphoma: Treatment can have late sequelae." ScienceDaily. ScienceDaily, 27 May 2015. <www.sciencedaily.com/releases/2015/05/150527092602.htm>.
Deutsches Aerzteblatt International. (2015, May 27). Hodgkin's lymphoma: Treatment can have late sequelae. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/05/150527092602.htm
Deutsches Aerzteblatt International. "Hodgkin's lymphoma: Treatment can have late sequelae." ScienceDaily. www.sciencedaily.com/releases/2015/05/150527092602.htm (accessed May 23, 2017).

RELATED STORIES